This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Orchid Chemicals & Pharmaceuticals Limited. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: The Contributions of Franklin Pooppady Xavier in Pharmaceutical Innovations
Introduction
Franklin Pooppady Xavier, a notable inventor based in Chennai, India, has made significant contributions to the field of pharmaceuticals. With a focus on developing novel compounds, his work seeks to address critical health issues such as obesity, inflammation, and diabetes.
Latest Patents
Franklin holds a patent for "Dipeptidyl peptidase IV inhibitors." This patent describes innovative compounds that are effective in lowering blood glucose, serum insulin, free fatty acids, cholesterol, and triglyceride levels. These compounds are particularly beneficial in treating obesity, inflammation, and autoimmune diseases, including multiple sclerosis and rheumatoid arthritis. Moreover, they play a vital role in the treatment and prophylaxis of type II diabetes.
Career Highlights
As an inventor, Franklin Pooppady Xavier has successfully contributed to the advancement of therapeutic solutions within the pharmaceutical industry. His patent showcases cutting-edge research that has the potential to improve the lives of many patients suffering from various metabolic disorders. His affiliation with Orchid Chemicals & Pharmaceuticals Limited highlights his commitment to bringing innovative solutions to market.
Collaborations
Franklin has collaborated with esteemed colleagues, including Gopalan Balasubramanian and Sukumar Sakamuri, to enhance the productivity and focus of his research. These collaborations reflect a cooperative spirit that is essential for driving innovation in complex fields like pharmaceuticals.
Conclusion
Franklin Pooppady Xavier’s work as an inventor has paved the way for advancements in medical treatments, especially concerning metabolic health. His patented compounds present promising opportunities for managing conditions that affect millions worldwide. Through continued collaboration and dedication to research, Franklin exemplifies the spirit of innovation within the pharmaceutical landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile